SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025088
Filing Date
2021-05-06
Accepted
2021-05-06 16:48:53
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atrs-10q_20210331.htm   iXBRL 10-Q 1422396
2 EX-31.1 atrs-ex311_6.htm EX-31.1 15726
3 EX-31.2 atrs-ex312_8.htm EX-31.2 15759
4 EX-32.1 atrs-ex321_9.htm EX-32.1 6462
5 EX-32.2 atrs-ex322_7.htm EX-32.2 6473
  Complete submission text file 0001564590-21-025088.txt   5175041

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atrs-20210331.xsd EX-101.SCH 31923
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atrs-20210331_cal.xml EX-101.CAL 37328
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atrs-20210331_def.xml EX-101.DEF 88185
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20210331_lab.xml EX-101.LAB 273908
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20210331_pre.xml EX-101.PRE 204397
11 EXTRACTED XBRL INSTANCE DOCUMENT atrs-10q_20210331_htm.xml XML 929322
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 21898635
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences